» Articles » PMID: 9182764

Cbfa1, a Candidate Gene for Cleidocranial Dysplasia Syndrome, is Essential for Osteoblast Differentiation and Bone Development

Overview
Journal Cell
Publisher Cell Press
Specialty Cell Biology
Date 1997 May 30
PMID 9182764
Citations 975
Authors
Affiliations
Soon will be listed here.
Abstract

We have generated Cbfa1-deficient mice. Homozygous mutants die of respiratory failure shortly after birth. Analysis of their skeletons revealed an absence of osteoblasts and bone. Heterozygous mice showed specific skeletal abnormalities that are characteristic of the human heritable skeletal disorder, cleidocranial dysplasia (CCD). These defects are also observed in a mouse Ccd mutant for this disease. The Cbfa1 gene was shown to be deleted in the Ccd mutation. Analysis of embryonic Cbfa1 expression using a lacZ reporter gene revealed strong expression at sites of bone formation prior to the earliest stages of ossification. Thus, the Cbfa1 gene is essential for osteoblast differentiation and bone formation, and the Cbfa1 heterozygous mouse is a paradigm for a human skeletal disorder.

Citing Articles

Fine-tuning of Wnt signaling by RNA surveillance factor Smg5 in the mouse craniofacial development.

Zhu S, Huo S, He W, Huang C, Zhang J, Jiang X iScience. 2025; 28(3):111972.

PMID: 40071146 PMC: 11894330. DOI: 10.1016/j.isci.2025.111972.


Loss of in Gli1 osteogenic progenitors prevents bone loss following ovariectomy.

Buchanan C, Chen S, Yuan Y, Guo T, Feng J, Zhang M JBMR Plus. 2025; 9(1):ziae141.

PMID: 39996169 PMC: 11848843. DOI: 10.1093/jbmrpl/ziae141.


Nuclear farnesoid X receptor protects against bone loss by driving osteoblast differentiation through stabilizing RUNX2.

Dong Q, Fu H, Li W, Ji X, Yin Y, Zhang Y Bone Res. 2025; 13(1):20.

PMID: 39885145 PMC: 11782663. DOI: 10.1038/s41413-024-00394-w.


PRDM16 Enhances Osteoblastogenic RUNX2 via Canonical WNT10b/β-CATENIN Pathway in Testosterone-Treated Hypogonadal Men.

Bathina S, Prado M, Fuenmayor Lopez V, Colleluori G, Aguirre L, Chen R Biomolecules. 2025; 15(1.

PMID: 39858473 PMC: 11764227. DOI: 10.3390/biom15010079.


Mesenchymal stem cell-mediated adipogenic transformation: a key driver of oral squamous cell carcinoma progression.

Shao Y, Du Y, Chen Z, Xiang L, Tu S, Feng Y Stem Cell Res Ther. 2025; 16(1):12.

PMID: 39849541 PMC: 11755832. DOI: 10.1186/s13287-025-04132-9.